These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Evaluation of imipenem/cilastatin sodium in the treatment of respiratory tract infections]. Shimokata K; Kawazu H; Nishiwaki K; Yamamoto M; Sakai S; Senda Y; Torii Y; Amano H; Saka H; Saito H Jpn J Antibiot; 1990 Jan; 43(1):14-22. PubMed ID: 2348550 [TBL] [Abstract][Full Text] [Related]
3. [Pharmacokinetic, bacteriological and clinical studies on imipenem/cilastatin sodium in neonates]. Iwai N; Nakamura H; Miyazu M; Kasai K; Taneda Y Jpn J Antibiot; 1989 May; 42(5):1087-101. PubMed ID: 2746858 [TBL] [Abstract][Full Text] [Related]
4. [Clinical evaluation of imipenem/cilastatin sodium as a second line regimen in severe infections associated with hematologic disorders]. Tsuda S; Nakai H; Murakami T; Seryu S; Takashima T; Tanaka S; Nakagawa H; Nishigaki H; Okuda T; Nishida K Jpn J Antibiot; 1991 Aug; 44(8):886-98. PubMed ID: 1920814 [TBL] [Abstract][Full Text] [Related]
5. [Clinical study of intramuscular imipenem/cilastatin sodium in the field of obstetrics and gynecology]. Matsuda S; Oh K; Tateno M; Kojima Y; Hirabayashi K; Okada E; Doko F; Kawai J Jpn J Antibiot; 1991 Dec; 44(12):1359-67. PubMed ID: 1798070 [TBL] [Abstract][Full Text] [Related]
6. Imipenem/cilastatin as secondary therapy for bacterial infections. Kono K; Onuki K; Tohara S; Takeda S Clin Ther; 1991; 13(4):448-56. PubMed ID: 1933995 [TBL] [Abstract][Full Text] [Related]
7. [Pharmacokinetic and clinical evaluation of imipenem/cilastatin sodium in neonates and premature infants. A study of imipenem/cilastatin sodium by a perinatal co-research group]. Fujii R; Sakata H; Inyaku F; Fujita K; Maruyama S; Yoshioka H; Hashira S; Tajima T; Nakazawa S; Sato H Jpn J Antibiot; 1989 Apr; 42(4):953-72. PubMed ID: 2671429 [TBL] [Abstract][Full Text] [Related]
8. [Therapeutic efficacy of imipenem/cilastatin sodium on respiratory tract infections in lung cancer patients]. Yamamoto M; Ina Y; Takada K; Noda M; Morishita M; Senda Y; Torii Y; Kakihara H; Yoshikawa K; Sugiura T Jpn J Antibiot; 1991 Apr; 44(4):388-97. PubMed ID: 1652653 [TBL] [Abstract][Full Text] [Related]
9. [Clinical evaluation of imipenem/cilastatin sodium in infectious complications of hematological malignancies. Tohkai Research Group on Infections in Hematological Disorders]. Naito K; Kobayashi M; Okumura M; Ikeda Y; Mitomo Y; Oguri T; Tanaka M; Ohara K; Kodera Y; Ohno R Jpn J Antibiot; 1990 Aug; 43(8):1371-80. PubMed ID: 2283705 [TBL] [Abstract][Full Text] [Related]
10. [Pharmacokinetic, bacteriological and clinical studies on imipenem/cilastatin sodium in neonates]. Hashira S; Tajima T; Fujii R Jpn J Antibiot; 1989 May; 42(5):1077-86. PubMed ID: 2746857 [TBL] [Abstract][Full Text] [Related]
11. [Clinical study of intramuscular imipenem/cilastatin sodium in the field of obstetrics and gynecology]. Chimura T; Banzai M; Yamazaki K; Miyata R; Yokoyama Y; Matsuo M; Oda T; Kihara K; Kanasugi H; Takahashi H Jpn J Antibiot; 1991 Dec; 44(12):1351-8. PubMed ID: 1798069 [TBL] [Abstract][Full Text] [Related]
12. [Chemotherapy with imipenem/cilastatin for severe infections accompanied by malignant hematological disorders]. Fujii Y; Inoue Y; Hiroshige Y; Kaku K; Kaneko T Jpn J Antibiot; 1993 Mar; 46(3):259-68. PubMed ID: 8510323 [TBL] [Abstract][Full Text] [Related]
13. [Clinical evaluation of imipenem/cilastatin sodium against severe infections in patients with hematopoietic disorders]. Tsukada T; Katayama N; Kageyama S; Nishikawa M; Kobayashi T; Deguchi K; Shirakawa S; Minami N Jpn J Antibiot; 1990 Dec; 43(12):2087-93. PubMed ID: 2086823 [TBL] [Abstract][Full Text] [Related]
14. [Imipenem/cilastatin sodium alone or combined with amikacin sulfate in respiratory infections]. Takamoto M; Ishibashi T; Toyoshima H; Tanaka H; Tamaru N; Watanabe K; Yoshida M; Tokunaga N; Ichikawa Y; Oizumi K Jpn J Antibiot; 1994 Sep; 47(9):1131-44. PubMed ID: 7990255 [TBL] [Abstract][Full Text] [Related]
15. Clinical efficacy of intravenous doripenem in patients with acute biliary tract infection: a multicenter, randomized, controlled trial with imipenem/cilastatin as comparator. Tazuma S; Igarashi Y; Inui K; Ohara H; Tsuyuguchi T; Ryozawa S; J Gastroenterol; 2015 Feb; 50(2):221-9. PubMed ID: 24795092 [TBL] [Abstract][Full Text] [Related]
16. [Clinical study of imipenem/cilastatin sodium in the perinatal period]. Yamamoto T; Yasuda J; Kanao M; Okada H Jpn J Antibiot; 1988 Nov; 41(11):1792-6. PubMed ID: 3210310 [TBL] [Abstract][Full Text] [Related]
17. Clinical evaluation of the imipenem/cilastatin combination in the therapy of severe infections in patients with malignant diseases. Cristiano P; Iovene MR; Simioli F; Pezza M; Raucci G; Lobello R Drugs Exp Clin Res; 1990; 16(6):293-7. PubMed ID: 2086164 [TBL] [Abstract][Full Text] [Related]
18. Imipenem-cilastatin in pediatric patients: an overview of safety and efficacy in studies conducted in the United States. Ahonkhai VI; Cyhan GM; Wilson SE; Brown KR Pediatr Infect Dis J; 1989 Nov; 8(11):740-4. PubMed ID: 2687787 [TBL] [Abstract][Full Text] [Related]
19. Imipenem/cilastatin (Primaxin): evaluation in general surgical practice. Chin MJ; Bagshaw PF; Bremner JM N Z Med J; 1991 Jan; 104(904):22-3. PubMed ID: 2008258 [No Abstract] [Full Text] [Related]
20. Treatment of severe pneumonia in hospitalized patients: results of a multicenter, randomized, double-blind trial comparing intravenous ciprofloxacin with imipenem-cilastatin. The Severe Pneumonia Study Group. Fink MP; Snydman DR; Niederman MS; Leeper KV; Johnson RH; Heard SO; Wunderink RG; Caldwell JW; Schentag JJ; Siami GA Antimicrob Agents Chemother; 1994 Mar; 38(3):547-57. PubMed ID: 8203853 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]